These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23781658)

  • 1. Comparison of essential drug list in a rural secondary care hospital in south India with Indian & World Health Organization list 2011.
    Rao SG; Thomas D; Zachariah S; Kannan MS; Alvarez-Uria G
    Indian J Physiol Pharmacol; 2012; 56(4):375-81. PubMed ID: 23781658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
    Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
    J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
    Logez SM; Hutin YJ; Holloway K; Gray R; Hogerzeil HV
    J Clin Pharmacol; 2004 Oct; 44(10):1106-13. PubMed ID: 15342611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs.
    Chaudhury RR; Parameswar R; Gupta U; Sharma S; Tekur U; Bapna JS
    Health Policy Plan; 2005 Mar; 20(2):124-36. PubMed ID: 15746221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing and dispensing activities at the health facilities of a non-governmental organization.
    Hazra A; Tripathi SK; Alam MS
    Natl Med J India; 2000; 13(4):177-82. PubMed ID: 11002683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National list of essential medicines of India: the way forward.
    Manikandan S; Gitanjali B
    J Postgrad Med; 2012; 58(1):68-72. PubMed ID: 22387654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selection and use of essential medicines.
    World Health Organ Tech Rep Ser; 2004; 920():1-127, back cover. PubMed ID: 15382605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of essential medicines lists: the South African case study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of drugs not listed in the National List of Essential Medicines: Findings from a prescription analysis by the Indian Council of Medical Research-Rational Use of Medicines Centres Network in tertiary care hospitals across India.
    Jhaj R; Banerjee A; Kshirsagar NA; Sadasivam B; Chandy SJ; Bright HR; Chugh PK; Tripathi CD; Badyal DK; Samuel MP; Medhi B; Prakash A; Joshi R; Kamat S; Tripathi R; Parmar UI; Dikshit H; Mishra H; Roy SS; Trivedi N; Chauhan J; Chatterjee S; Bhattacharya M; Desai CK; Sheth S; Gupta P; Roy A; Raveendran R; Mathaiyan J; Jeevitha G; Kaushal S; Gupta K; Jain S; Kaul R
    Indian J Pharmacol; 2022; 54(6):407-416. PubMed ID: 36722552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
    Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
    Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India.
    Chatterjee S; Mandal A; Lyle N; Mukherjee S; Singh AK
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1141-5. PubMed ID: 17823977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.
    Roy V; Singhal S; Tayal H; Dubey AP
    Indian J Pediatr; 2021 Mar; 88(3):227-234. PubMed ID: 32086758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2009; (958):1-242, back cover. PubMed ID: 20560299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of follow-on drugs and indications on the WHO Essential Drug List.
    Cohen J; Cabanilla L; Sosnov J
    J Clin Pharm Ther; 2006 Dec; 31(6):585-92. PubMed ID: 17176363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).
    World Health Organ Tech Rep Ser; 2003; 914():i-vi, 1-126. PubMed ID: 12872478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Health Organization program for the selection and use of essential medicines.
    Reidenberg MM
    Clin Pharmacol Ther; 2007 Apr; 81(4):603-6. PubMed ID: 17314928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A baseline survey on use of drugs at the primary health care level in Bangladesh.
    Guyon AB; Barman A; Ahmed JU; Ahmed AU; Alam MS
    Bull World Health Organ; 1994; 72(2):265-71. PubMed ID: 8205647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical look at the ophthalmological preparations in the national list of essential medicines of India 2011.
    Prakash VB
    J Postgrad Med; 2013; 59(2):159-60. PubMed ID: 23793326
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring progress in neglected disease drug development.
    Cohen JP; Sturgeon G; Cohen A
    Clin Ther; 2014 Jul; 36(7):1037-42. PubMed ID: 24906971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
    World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.